AI assistant
Croda International PLC — Director's Dealing 2020
Mar 30, 2020
4641_dirs_2020-03-30_ddaa1098-acbf-4efe-bebf-b59aef682439.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0209I
Croda International PLC
30 March 2020
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mrs Yootha Jane Arnott
2
Reason for the notification
a)
Position/status
PCA of PDMR (Mr Stuart Arnott)
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Croda International Plc
b)
LEI
2138004WCNBFJEEOXV26
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of 10.609756p each
ISIN: GB00BJFFLV09
b)
Nature of the transaction
1)
Sale of shares as detailed in c) below.
2)
Purchase of shares as detailed in c) below.
3)
Transfer of shares into an ISA as detailed in c) below.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) | |
| 1) | 4200p | 436 |
| 2) | 4208.84p | 436 |
| 3) | Nil | 436 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregated volume | Aggregated Price | |
| 1) | 436 | £18,312.00 |
| 2) | 436 | £18,350.54 |
| 3) | 436 | Nil |
e)
Date of the transaction
2020-03-27
f)
Place of the transaction
XLON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHVBLBXBXLZBBV